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ABSTRACT 
Acquisition of full developmental competence of oocytes not only occurs during 
growth stage, and the final preparation during oocyte maturation is also critical. 
Previous studies have shown that nuclear maturation can occur spontaneously 
following culture in vitro; however, there may be some insufficiency in cytoplasmic 
maturation of the in vitro matured oocytes. But till now, the differences of the events 
of cytoplasmic maturation between in vitro and· in vivo matured oocytes are still not 
clear. Ovarian stimulation by gonadotrophins is used to permits the growth and 
development of follicles, to time the initiation of pre-ovulatory oocyte maturation, and 
to increase the numbers of oocytes ovulated. It is one of the foundations of CUITent 
treatments of human infertility. The success of clinical IVF has been depending on 
generation of matured oocytes at high frequency. However, ovarian stimulation with 
gonadotropins is associated with side effects and complications. 
In order to illuminate mechanisms which affect the developmental competence 
of oocytes produced in vitro, in the present study, we have compared the difference of 
the quality of oocytes produced in vitro with that of the oocytes produced in vivo using 
mouse model. In order to understand the relationship between oocyte competence and 
ovarian responses to stimulation in the mouse, we also have compared difference of 
the quality of oocytes produced in vitro or in vivo from gonadotrophns stimulated 
ovaries with that of from natural cycling ovaries. 
In-vitro matured oocytes were collected from 1) naturally ovulated mice and 2) 
superovulated (PMSG + hCG) mlce. Immature oocytes were retrieved from 3) 
naturally cycling mice, and 4) from mice primed with PMSG. The results indicate that 
the percentages of cleavage and blastocyst formation are significantly different 
(P<O.05) between in-vivo and in-vitro matured oocytes. Blastocyst formation rate is 
significantly higher (P<O.05) in immature oocytes derived from PMSG primed mice 
compared to immature oocytes derived from naturally cycling mice. The percentages 
of oocytes with cornet tails and the length of cornet tails are significantly higher and 
longer respectively in in-vitro matured oocytes compared to in-vivo matured oocytes. 
Total cell numbers of blastocyst are also significantly different (P<O.05) between 
in-vivo and in-vitro matured oocytes. However, there are no differences in ratio of 
trophectoderm (TE)/inner cell mass (lCM) between in-vivo and in-vitro matured 
oocytes. In conclusion, in-vivo matured mouse oocytes are more competent than those 
of matured in-vitro, suggesting that it may be due to its less damage of DNA. 
Embryonic development capacity of in-vivo matured oocytes is not promoted by 
ovarian stimulation. Gonadotropin priming prior to immature mouse oocyte retrieval 
is beneficial to subsequent embryonic development. 
Keywords: mouse oocyte, IVM, IVF, gonadotropin, development 
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RESUME (French) 
Des oocytes maturés in vivo ont été prélevés sur: 1) des souris ovulées naturellement; 
et 2) des souris superovulées (PMSG + hCG). Des oocytes immatures ont été prélevés 
sur: 3) des souris à cycles naturels; et 4) des souris préparées au PMSG. Les résultats 
indiquent que les pourcentages de formation de clivages et de blastocystes sont 
significativement différents (P<O.05) entre les oocytes maturés in vivo et in vitro. Le 
taux de formation de blastocystes est significativement plus élevé (P<O.05) chez les 
oocytes immatures issus de souris préparées au PMSG, comparés aux oocytes 
immatures issus de souris aux cycles naturels. Les pourcentages d'oocytes à queues de 
comète sont plus élevés, et les queues de comète significativement plus longues chez 
les oocytes maturés in vitro comparés aux oocytes maturés in vivo. Les nombres 
totaux de cellules des blastocystes sont aussi significativement différents (P<O.05) 
entre les oocytes maturés in vivo et in vitro. Cependant, il n'y a pas de différence dans 
le ratio trop hecto derme (TE)/ masse interne de la cellule (lCM) entre les oocytes 
maturés in vivo et in vitro. En conclusion, les oocytes de souris maturés in vivo sont en 
meilleur état que les oocytes maturés in vitro, ce qui suggère un lien avec une moindre 
détérioration de l'ADN. La capacité de développement embryonnaire des oocytes 
maturés in vivo n'est pas favorisée par la stimulation ovarienne. Par contre, la 
préparation à la gonadotropine avant prélèvement des oocytes de souris immatures est 
bénéfique au développement embryonnaire subséquent. 
Mots clés: oocytes de souris, IVM, IVF, gonadotropine, développement 
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INTRODUCTION 
Folliculogenesis is a relatively long process from recruitment of follicles as the 
primordial to preovulatory stage (Gougeon, 1996). The later stage of folliculogenesis 
from antral to preovulatory follic1es has been considered gonadotropin dependent and 
is regulated by the cyclic changes of follicle-stimulating hormone (FSH) and 
luteinizing hormone (LH), in which this period normally is two weeks before 
ovulation in women. During the follicular phase of the menstrual cycle, although 
approximately 20 antral follic1es are selected, only a single follic1e usually grows to 
preovulatory stage and releases its oocyte for potential fertilization (Hillier, 1994). 
To date, most of in-vitro fertilization (IVF) protocols use gonadotropin stimulation 
regimens to stimulate the ovaries for 2 or 3 weeks in order to producing multiple 
preovulatory follic1es. The number of oocytes obtained relates to the embryos 
available for transfer and this directly affects the probability of successful pregnancy. 
However, ovarian stimulation with gonadotropins is associated with side effects and 
complications, most prominently ovarian hyperstimulation syndrome (OHSS). In 
addition, there is long-term sicle effect with risk of ovarian cancer by repeated 
gonadotropin stimulation and it is also financially challenging to use gonadotropins 
(Brinton et al., 2005). 
There is an increasing interest in the use of in-vitro matured (IVM) oocytes as 
a clinical treatment. IVM treatment for infertile women has several advantages, 
inc1uding the elimination of side effects associated with gonadotropin stimulation, 
especially the risk of OHSS, reduced cost, and less complicated treatment protocol. 
Recently, significant progress has been made to improve pregnancy and implantation 
rates from in-vitro matured oocytes (Chian et al., 2004). Although in-vitro maturèd 
oocytes can be fertilized and developed in-vitro, the pregnancy and implantation rates 
of these c1eaved embryos remain lower than the embryos developed from in-vivo 
matured oocytes. Apart from improving the in-vitro culture condition for immature 
oocytes, the origins of immature oocytes have been taken into account of successful 
IVM treatment. The endocrine environment of follic1es in the latter stage of 
folliculogenesis has a profound impact on the oocyte quality (Chian et al., 2004). 
During the final stage of this phase, although the size of primary oocyte does not grow 
significantly, the oocyte resumes meiosis and undergoes nuc1ear and cytoplasmic 
maturation (Hardy et al., 2000). 
Techniques have been established for isolating and culturing immature oocytes 
from antral foUic1es (Eppig et al., 1992; Eppig and O'Brien, 1996). In-vivo priming 
with FSH prior to immature oocyte retrieval followed by IVM has been reported in 
many species inc1uding humans, indicating that mild ovarian stimulation with FSH 
prior to immature oocyte retrieval markedly improved the proportion of the oocyte 
maturation and fertilization as weIl as embryonic development (Vanderhyden and 
Armstrong, 1990; Schramm and Bavister, 1994; Wynn et al., 1998; Mikkelsen and 
Lindenberg, 2001). In contrast, it has been indicated that priming with FSH before 
immature oocyte retrieval resulted in no difference in oocyte maturation, fertilization 
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and embryonic development (Trounson et al., 1998; 2001; Lin et al., 2003). Therefore, 
it is important to understand the effect of the systemic endocrine environment prior to 
immature oocyte retrieval on oocyte maturation and subsequent embryonic 
development. 
In addition, different stimulation reglmens are believed to directly affect 
oocyte quality and subsequent embryonic development as well as successful 
pregnancy (De Sutter etai., 1991). Interestingly it also indicated that oocyte and 
embryo quality are superior when recombinant FSH was used for ovarian stimulation 
compared with urinary FSH (Racowsky et al., 2005). Although most of the oocytes 
are matured from stimulated ovaries 36 hours after human chorionic gonadotropin 
(hCG) administration, it is not uncommon to retrieve few immature oocytes despite 
having been exposed to an ovulatory dose of hCG before aspiration. These immature 
oocytes are capable of undergoing spontaneous nuc1ear maturation in-vitro, and then 
normal fertilization and development in-vitro. However, the pregnancy rate is 
extremely low following transfer of the embryos derived from these immature oocytes 
(Veeck et al., 1983; Prins et al., 1987; Nagy et al., 1996; Liu et al., 1997; Jaroudi et al., 
1997; Edirisinghe et al., 1997). Developmentally lethal chromosomal abnormalities 
are common defects noted in mature human oocytes, affecting more than 25% of 
normal-Iooking mature human oocytes retrieved from stimulated ovaries (Delhanty 
and Handyside, 1995; Wall et al., 1996). Indeed, it has been reported that aneuploidy 
occurs at high rates in mature human oocytes (20-31 %) recovered from the stimulated 
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ovaries (Pellestor, 1991; Gras et al., 1992; Hodges et al., 2002). It appears that the 
oocyte quality can be influenced by local ovarian milieu and circulating endocrine 
environment (Papanikolaou et al., 2005; Von Otte et al., 2005). Nevertheless, it is 
unclear so far whether these abnormalities are caused by the artificial ovarian 
stimulation regnnens. Therefore, it is important to understand the relationship 
between follicular environment prior to mature or immature oocyte retrieval and the 
oocyte quality. 
4 
OBJECTIVES 
The objective of this study was to examine whether the developmental competence of 
immature oocytes is compromised by different local endocrine environment of the 
follicles using mouse model. Further, to examine whether ovarian stimulation by 
gonadotropins affects the oocyte quality and subsequent embryonic development. 
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LITERATURE REVIEW 
Ovarian structure and oogenesis 
Morphologically, the ovary has three regions: an outer cortex that contains the oocytes 
and represents most of the mass of the ovary. The cortex is enveloped by the germinal 
epithelium, contains the foUic1es, which are the functional units of the ovary. They are 
present in different states of development or degeneration (atresia), each enc10sing an 
oocyte. In addition to the oocyte, ovarian follic1es have two other cellular components: 
granulose cells, which surround the oocyte, and theca cells, which are separated from 
the granulose cells by a basal membrane and are arranged in concentric layers around 
this membrane. The foUic1es are embedded in the stroma, which is composed of 
supportive connective cells similar to that of other tissues, interstitial secretary cells 
and neurovascular elements. The inner medulla, formed by stromal cells and cells with 
steroid-producing characteristics; and the hilum, which, in addition to serving as the 
point of entry of the nerves and blood vessels, represents the attachment region of 
gland to the mesovarium (Guraya 1974; Gosden 2002). 
Folliculogenesis is a continuous developmental process. The primordial germ 
cells originate in the endoderm of the yolk sac, allantoids, and hindgut of the embryo. 
By 5-6 weeks of gestation they migrate to the genital ridge and begin to multiply 
rapidly, so that by 24 weeks of gestation the total number of oogonia is about 7 
million. Sorne of them reach the prophase stage of meiosis and are called primary 
oocytes. Many others degenerate and die, so that at birth, each ovary has more than 
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500,000 healthy non-growing follicles, and only 2 million primary oocytes remain, a 
number that is further reduced before puberty to about 400,000 (Baker, 1963).The 
earliest follicular growth phase is determined mainly by an increase in oocyte size and 
forms a few layers of granulose cells around oocyte. Primordial foUicles are formed 
when a single layer of flattened epithelial cells surrounds a primary oocyte. When the 
flattened epithelial cells become cubical, the follicle becomes a primary follicle. The 
oocyte secretes a mucoid substance rich in glycoprotein that forms a band called zona 
pellucida. Development of primary foUicles is a very slow process lasting for several 
years. In some foUicles the continuity of the granulose cell layers is disrupted by the 
appearance of spaces fiUed with fluid. Gradually, these spaces become confluent, 
forming a single central cavity called the antrum. The follicles with these 
characteristics are known as antral foUicles. In the antral phase, which is initiated in 
response to FSH secreted by the anterior pituitary, fluid accumulates between 
granulose cells. As they grow further, their antrum is greatly expanded. These follicles 
are known as graafian foUicles. At this stage, the oocyte reaches its maximum size 
(150 )..Im). As the granulose cells continue to proliferate and antrum enlarges, the 
oocyte is displaced from the center of the follicle and becomes surrounded by a 
hillock of granulose cells called the cumulus oophorus. By the end of this stage, the 
antral foUicle has reached a diameter of 5 mm. At this developmental stage, the 
follicles become gonadotrophin-dependent for further development. A large increase 
in plasma levels of gonadotropins takes place at the end of the foUicular phase. This 
1'-
1 surge greatly enhances the production of antral fluid in the dominant follicle; the 
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follicle enlarges, reaching a diameter of 10-20 mm in 48 hours (Gosden and Bownes, 
1995). The granulosa become less cohesive and cumulus oophorus loosens. One 
follicle becomes dominant and undergoes further growth so as to finally expel its 
oocyte at ovulation (Figure 1). 
Figure 1. Section of the ovary. Showing the anatomic parts and the sequence of 
developmental stages of the follicles (Knight and Glister, 2003). 
Concepts of oocyte maturation 
The first meiotic division is completed at the time of ovulation. The first polar body is 
eliminated, and the oocyte is captured by the fimbria of the oviduct, which is closely 
applied to the surface of the ovary. The oocyte is then transported to the ampulla of the 
oviduct via ciliary movement. The second meiotic division occurs at the time of 
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fertilization, yielding the ovum with a haploid number of chromosomes and a second 
polar body that is discarded. Oocyte maturation is defined morphologically as the 
re-initiation and completion of the first meiotic division from the germinal vesic1e 
(GV) stage to the metaphase-II (M-II) stage, and the accompanying cytoplasmic 
processes occurring within the oocyte that are essential for fertilization and that 
support early embryo development (Gary, 2001). Oocyte maturation is often 
conceptually divided into nuc1ear and cytoplasmic maturation. Nuc1ear maturation is 
termed as when meiosis resumes, the oocyte undergoes germinal vesic1e breakdown 
(GVBD), or dissolution of the nuc1ear envelope. Subsequently chromatin condenses 
into discrete bivalents that align on the meiotic spindle at metaphase-I (M-I). During 
anaphase and telophase I, bivalents separate. This separation is complete at M-II, by 
the presence of the first polar body. Cytoplasmic maturation is the processes 
modifying the oocyte cytoplasm that are essential for fertilization and 
pre-implantation embryonic developmental competence inc1uding production and 
presence of specific factors, the relocation of cytoplasmic organelles and the 
post-transcriptional modification of mRNAs that have accumulated during oogenesis 
(Trounson et al., 2001 ). 
Nuclear maturation 
It was back in 1978 that cyc1ic adenosine monophosphate (cAMP) was identified as 
oocyte "meiotic arrestor" (Dekel and Beers, 1980). cAMP generated by the somatic 
cells of the ovarian follic1e is transmitted to the oocyte through gap junctions. The gap 
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junctions pennit regulatory molecules, such as steroids, cce+, inositol, 1, 4, 
5-trisphohate (IP3) and cAMP to pass between the cytoplasm of oocyte and cumulus 
cells. cAMP maintains the oocyte in meiotic arrest and re-initiation of meiosis is 
subsequent to a drop in intra-oocyte concentration of cAMP. The pre:-ovulatory LH 
surge in-vivo initiates GVBD. Reinitiating of meiosis and its progression to M-I stage 
depends on the activation of maturation promoting factor (MPF) (Masui and Markert, 
1971), which are protein dimmer composed of catalytic p34cdc serine/threonine kinase 
and the regulatory cyc1inB subunit (Gautier et al., 1988). This p34cdc2/cyclinB1 
heterodimer is initially fonned as in active pre-MPF and is activated by the dual 
specificity cdc25 phosphatase upon dephophosphorylation on thr14 and tyr 15 of 
p34cdc2 (Gould et al., 1989). MPF activity is elevated immediately after reinitiating of 
meiosis before GVBD, reaches maximal 1evels at M-I, dec1ines just prior to he 
fonnation of first polar body and rises again before entry into the second meiotic 
division. MPF activation is triggered by reduction in intra-oocyte cAMP (Josefsberg et 
al., 2003). 
Many studies have shown that mitogen-activated protein kinase (MAPK) 
pathway is frequently involved in meiotic resumption. Activated MAPK kinase is 
required for a further increase in MPF activity and meiosis progress beyond MI 
(Trounson et al, 2001). It is known that the product of c-mos, MûS, is a protein 
serine/threonine kinase which is expressed early in oocyte maturation and disappears 
immediately after fertilization (Sagata et al., 1989). Mos stimulate MAPK activity, but 
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do not activate p34cdc2 (Nebreda and Hunt, 1993). Accumulating evidence suggests 
that MAPK activity is not required for the spontaneous meiotic resumption of mouse 
and rat oocytes, under the in-vitro conditions, gonadotrophin-induced GVBD requires 
the participation of MAPK activity in the cumulus cells (Su et al., 2002), and 
induction of cumulus expansion also requires the participation of MAPK. MAPK 
pathway is associated with cytoplasmic events including the regulation of microtubule 
dynamics, spindle assembly and chromosome condensation. 
Cytoplasmic maturation 
In the course of an oocyte grows and matures, cytoplasmic changes occur that may 
include such cellular processes as mRNA transcription (Hunter and Moor, 1987), 
protein translation (Sirard et al., 1989), post-translational modification of proteins 
(Levesque and Sirard, 1995), and ultrastructural changes (Dieleman et al., 1983). 
RNA synthesis continues at a low level to within 1 hour of GVBD and sorne of the 
newly synthesized RNA is released into cytoplasm before GVBD (Wassarman and 
Letoumeau, 1976). Protein synthesis increases obviously before GVBD in human 
oocytes during maturation culture, suggesting that these newly synthesized proteins 
may be important for subsequent embryonic development (Chian et al., 1999). It has 
been known that the metabolism of the oocyte is characterized by active transcription 
and translation during the pre-ovulatory period (Wassarman and Kinloch, 1992). The 
oocyte and early pre-embryo are depended upon the pool of rnRNA and protein 
accumulated during the pre-ovulatory period (Telford et al., 1990). Cytoplasmic 
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factors of the oocyte are also dependent on maternaI genetic background, and maybe 
responsible for maternaI effects on de-novo methylation, gene expression and 
congenital aberrations (Pickard et al., 2001). 
In-vitro studies on mouse oocytes have shown that two c10sely related sterols, 
subsequently named meiosis-activating sterols (MAS), can overcome the inhibitory 
effect of hypoxanthine on the resumption of meiosis (Byskov et al., 1995). Two 
sterols (4,4-dimethyl-5a-cholest-8, 14,24-triene-3a-ol from follicular fluid and 
4,4-dimethyl-5a-cholest-8,24-diene-3p-ol), as well as two c10sely related synthetic 
c29 sterols, modestly increased the proportion of maturing mouse oocytes cultured 
with hypoxanthine as an inhibitor. FSH triggers the synthesis by cumulus cells of 
MAS that may reach the oocytes through the gap junction pathway to bring about 
meiotic resumption (leonardsen et al., 2000). The proposed mechanism of MAS on 
oocytes maturation is that MAS produced by the somatic compartrnent of follic1e and 
acts directly on the oocytes to stimulate maturation. However, recent studies suggested 
that MAS is not an obligatory step in the stimulation of the resumption of meiosis, 
indicating MAS production in oocytes rather than its transport from the somatic cells 
as implied by the proposed role of MAS as a cumulus-oocyte signal molecule (Down 
et al., 2001; Vaknin et al., 2001). Therefore, it seems that a role for MAS in meiotic 
regulation and the effect of gonadotropin stimulation on the sterol biosynthetic 
pathway remain inconc1usive (Chian et al., 1999). Nuc1ear and cytoplasmic 
maturation occur in a synchronized manner in-vivo, and any alteration in this 
12 
synchrony may compromise the developmental competence of the oocytes (Salamone 
et al, 2001). 
Gonadotropins . 
FSH and LH produce by anterior pituitary are essential for normal sexual development 
and reproductive function. Although the importance of gonadotropins in gonadal 
development and reproductive function has been established, the mechanism of 
gonadotropins on follicle growth and oocytes maturation is not fully understood. 
Follicular growth and oocyte maturation in-vivo is FSH dependent. In the ovary FSH 
binds to FSH receptors located on granulose cells and acts via the cAMP dependent 
protein kinase pathway. FSH has been reported to activate granulose cell proliferation 
and differentiation, and to reduce the number of atretic follicles grown in-vitro in 
rodents (Roy and Greenwald, 1989), cows (Hulshof et al., 199) and humans (Roy and 
Treacy, 1993). FSH binding in the presence of androgen also stimulates progesterone 
biosynthesis (Toaff et al., 1983). FSH also induces the gene for tissue-type 
plasminogen activator (tPA), a protease that leads to digestion of the follicular wall at 
ovulation (Ny et al., 1985). More studies showed that action of gonadotrophin on 
oocyte maturation is dependent on new mRNA and protein synthesis, but is not 
mediated by increases in steroid synthesis (Thomas et al., 2001). 
Induction of LH receptors by FSH is one of the hallmarks of the differentiating 
granulose cells mediated by the FSH-induced increase in intracellular cAMP 
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(Erickson et al., 1982). Theca cells constitutionally contain LH receptors. LH is 
capable of stimulating androgen production from theca cells into FSH-stimulated 
granulose cells to transform estrogen (Kamitis et al., 1994). LH is thought to stimulate 
progesterone production of granulose and cumulus cells in pre-ovulatory follicles 
(Chian et al., 1999). LH may synthesize with FSH to sustain foUicle development as 
weIl as to prepare it for mid-cycle LH surge that triggers ovulation. Although it has 
been reported that LHR can be down-regulated by high concentrations of human 
chorionic gonadotropin (hCG) or LH once the LH receptor has been induced by FSH 
in mural granulose cells (Schwall and Erickson, 1983), the reaction of LH on LH 
receptor mRNA in the mural granulose cells and cumulus cells is poody understood. 
Possible participating factors in oocytes maturation during oocytes maturation is 
shown in Figure 2 (Chian et al., 2004). 
Ovarian stimulation by gonadotrophins is used to permits the growth and development 
of follicles, to time the initiation of pre-ovulatory oocyte maturation, and to increase 
the numbers of oocytes ovulated. It is one of the foundations of CUITent treatments of 
human infertility. The success of clinical IVF has been depending on generation of 
matured oocytes at high frequency. The gonadotropins are either in the form ofurinary 
extract or recombinant forms. However, ovarian stimulation with gonadotropins is 
associated with side effects and complications. Patients may have irritation or rashes 
at the site of injection, while others may complain of nausea and headaches. By far the 
most pro minent side effect is OHSS. This syndrome occurs in approximately 3% 
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(Yovich, 1995) of women JeceIvmg the drugs and may result m 
FSH LH 
t t 
FSHR LHR 
Cumulus cell 0 Cumulus cell P4 
Oocyt e 
Figure 2. Hypothetical model for the possible participation of factors in oocytes 
maturation. FSS: follic1e-stimulating honnone; LH: luteinizing honnone; FSHR: FSH 
receptor; LHR: LH receptor; GV: Genninal vesicle; E2: estradiol; P4: progesterone; 
ER: estradiol receptor; PR: progesterone receptor (Chian et al., 2004). 
massIve ovanan enlargement, abdominal distension, respiratory distress, unnary 
distension, renal failure (Bider et al., 1989; Elchalal et al., 1997). In addition, there is 
long-tenn si de effect with risk of ovarian cancer by repeated gonadotropin stimulation 
and it is also financially challenging to use gonadotropins (Brinton et al., 2005). These 
negative effects were proposed due to changed local endocrine environment and 
impaired oocyte quality (Van der Auwera and D'Hooghe, 2001). An understanding of 
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the relationship between oocyte competence and ovarian responses to stimulation in 
the mouse may pro vide insights into the origin of oocyte defects that could be of 
clinical relevance in the diagnosis and treatment ofhuman infertility. 
In-vitro maturation of oocytes 
In-vitro maturation (IVM) of oocytes can be defines as the act of culturing and 
maturing oocytes that have been harvested at immature states. Mammalian oocytes 
were matured in-vitro for the first time in 1935 (Pincus and Enzmann, 1935). After 
liberating the oocyte from an unstimulated rab bit follicle, they observed that the 
oocyte spontaneously underwent GVBD and progressed to M-II stage of meiosis. 
With the development of culture conditions, in-vitro matured oocytes are capable of 
fertilizatidn and undergoing embryo development in-vitro. IVM technology has been 
applied to a number ofmammalian species, including the mouse (Donahue 1968), cow 
(Fukui and Sakuma, 1980), horse (Willis et al., 1991), cat (Johnston et al., 1989), 
sheep (Mo or and Trounson, 1977), and pig (Kikuchi et al., 1999). 
In 1965, Edwards confirmed the ability ofhuman oocytes to mature in vitro, if 
placed in an appropriate culture medium and 3 years later the first successful 
fertilization of oocytes matured in vitro was reported (Edwards et al., 1969). There 
after, successful pregnancies and deliveries were achieved at sorne centers following 
IVM (Cha and Chian, 1998). The first birth after IVM of immature oocytes occurred 
after oocytes were collected during a Caesarean section for oocyte donation (Cha et al., 
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1991). 
Mammalian oocytes acqmre a senes of competences during follicular 
development (oocyte growth and maturation) that play critical roles at fertilization and 
subsequent early embryonic development. Early studies have shown that nuclear 
maturation occurs spontaneously following culture in-vitro of animal and human 
immature oocytes. However, the developmental competence after fertilization of these 
oocytes is questionable. Oocyte maturation in-vitro is profoundly affected by culture 
conditions. The percentage of oocytes that can develop to die blastocyst stage is 
practically considered a suitable indication of developmental competence. However, 
recent data from animal studies suggested that "blastocyst formation" is a limited 
predictor of development (Duranthon and Renard, 2001). The successful production of 
morphologically normal blastocyst stage embryos has not proved reliable in indicating 
whether a successful pregnancy will be established. There are differences in the 
relative abundance of a set of developmentally important gene transcripts in bovine 
morulae and blastocysts between culture systems and protein supplements (Wrenzycki 
et al., 2001; Rizos et al., 2002). Therefore, expression of these genes could be 
potentially important markers for assessing embryo viability and implantation. 
However, it is difficult for clinical practice to use these important markers at the 
present time. Further research is required to develop reliable marker for assessing 
oocyte and embryo viability. 
Nowadays IVM is a new alternative method for treatment of women with 
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infertility, especially when the patient is infertile due to polycystic ovarian disease 
(PCOD) (MacDougall et al., 1992). In general, the polycystic ovary is one that 
contains ten or more small cysts (2-8 mm in diameter), arranged in a dense stroma. In 
sorne cases there is elevated basal LH level and testosterone levels in the blood. Sorne 
patients also have other kind of cyclic disturbances such as overweight, hirsute. Up to 
43% of patients undergoing IVF treatment suffer from PCOD (MacDougall et al., 
1994), and therefore at a high risk of receiving OHSS after exogenous gonadotropin 
stimulation. The benefits of IVM include avoiding the side effects of GnRHa and 
gonadotropins, avoiding the required ultra sound and serum monitoring, and avoiding 
the risks of ovarian stimulation. NM also seem to be ofbenefit for ovum donation, by 
banking the oocytes as in sperm donation programs, and in storing of oocytes for later 
use (Wood et al., 1997). However, the pregnancy and implantation rates of the 
cleaved embryos from in vitro matured oocytes remain lower than the embryos 
developed from in vivo matured oocytes. Comparison of the differences between 
in-vitro and in-vivo matured oocytes can give us the opportunity to illuminate 
, mechanisms which affect the developmental competence of oocytes produced in-vitro. 
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MATERIALS AND METHODS 
Animais 
Mice (CD1, female: 8-10 weeks-old; male: 10-12 weeks-old) were employed in this 
study. The mice were housed in a temperature- and light-controlled room, and free 
access to the food and water under a photoperiod of 12 hours-light and 12 hours-dark. 
The experimental proto cols and animal handling procedures were reviewed and 
approved by Animal Ethics Committee of McGill University. 
Immature and mature oocytes from ovaries stimulated by gonadotropins 
Mature oocytes are defined here as the oocytes extruded first polar body (lPB) into its 
pelliviteline space (PVS), and immature oocytes refer the oocytes contained germinal 
vesicle (GV) in its cytoplasm. Female mice were injected intraperitoneally with 5.0 ru 
of pregnant mare stimulating gonadotropin (PMSG; Sigma Chemical Co., St. Louis, 
MO, USA). For mature oocyte collection, the female mice were further injected 
intraperitoneally with 5 lU ofhCG (Sigma) after 48 hours ofPMSG injection. Post 14 
hours of hCG injection, the mice were humanely killed and the oviducts were 
dissected and placed into a Petri-dish containing modified human tubai fluid -HEPES 
buffered medium (mHTF-HEPES; Quinn et al., 1995) supplemented with 1.0 mg/ml 
bovine serum albumin (BSA; Sigma). Cumulus-oocyte complexes (COCs) were 
released by tearing the ampullae of the oviducts, and COCs were used for in-vitro 
fertilization (IVF) or other experiments. For immature oocyte collection, the mice 
were sacrificed after 48 hours of PMSG injection and the ovaries were dissected and 
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r-.. placed mHTF-HEPES supplemented with 1.0 mg/ml BSA. The visible foUicles were 
punctured under a stereomicroscope using 25-gauge needle. The compacting COCs 
were collected for IVM culture. 
Immature and mature oocytes from natural cycling ovaries 
For mature oocyte collection, the natural cycling female mice were mated with a 
vasectomized male. Briefly, the female and the male mice were caged together in the 
evening before the day of oocyte collection. After checking vagina-mating plug the 
next moming, the female mice were killed and dissected the oviducts into a Petri dish. 
By tearing the ampullae, the COCs were released and collected for IVF or other 
experiments. For immature oocyte collection, the natural cycling mice (without any 
stimulation with gonadotropins) were killed, and the ovaries and oviducts were 
dissected and placed into a Petri dish containing mHTF-HEPES. Before puncturing 
the visible follicles, the oviducts were checked to ensure that there were no COCs 
ovulated into the ampullae from the ovaries under a stereomicroscope. The visible 
follicles were punctured using 25-gauge needle. The fully growing immature oocytes 
(GV) surrounded with cumulus cells from antral follicles were selectively collected 
for IVM culture. 
In-vitro maturation (IVM) of immature oocytes 
After collection of immature COCs, they were rapidly washed three times in 
mHTF-HEPES containing 1.0 mg/ml BSA and then for maturation in culture. Oocyte 
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maturation involved placing the COCs in Oocyte Maturation Medium (Cooper 
Surgical/SAGE, USA) supplemented with 10% fetal bovine serum (FBS), and 75 
mIU/ml recombinant human FSH and LH (Serono, Canada). Briefly, following 
washing, 30-40 selected COCs were cultured for 17-18 hours in an Organ Tissue 
Culture Dish (60 X 15 mm; Falcon) containing 1.0 ml of Oocyte Maturation Medium 
in an incubator at 37.0°C with an atmosphere of 5% C02 and 95% air and high 
humidity. Following maturation in culture, COCs were denuded from cumulus cells 
by mechanically pipetting with a fine diameter pipette in mHTF-HEPES 
supplemented with 85 unit/ml hyaluronidase for assessment of maturity. The mature 
oocytes were determined by the presence of a first polar body extrusion under a 
stereo microscope, and then the mature oocytes were prepared for IVF and other 
experiments. 
Assessment of DNA damage in oocytes 
Detection of DNA fragmentation in individual oocyte was carried out with slight 
modification of the method described by Singh et al. (1988) and Takahashi et al. 
(1999). In brief, COCs were removed from cumulus cells by mechanically pipetting 
with a fine diameter pipette in mHTF-HEPES containing 85 unit/ml hyaluronidase, 
and then zona pellucida was removed by Tyrode's solution acidic (Sigma) digestion. 
The oocytes were washed twice in phosphate buffered saline (PBS) supplemented 
with 4.0 mg/ml polyvinylpyrrolidone (PVP-360; Sigma), at the meantime, 1 % low 
me1t preparative grade agarose (20 f.ll of drop let) were loaded on a slide pre-coated 
21 
with 1 % high strength analytical grade agarose. The oocytes then were quickly placed 
in the bottom of the agarose drop let and immediately covered by cover slip. The slides 
were placed on ice for 30 minutes to solidify the agarose, and then the coverslip was 
carefully removed. The oocytes were lysed by incubating the slides for 2 hours at 4°C 
in lysing buffer composed of 10 mM Tris, pH 10, containing 1 % sodium sarcosinate, 
2.5 mM NaCI, 100 mM Na2-EDTA, and 1% Triton X-100. After removing from the 
lysing solution and washing with distilled water, the slides were placed on a horizontal 
gel electrophoresis unit. The unit was filled with fresh electrophoresis buffer (1.0 mM 
Na2-EDTA, 300 mM NaOH) to a level 0.25 cm above the slides, and the slides 
equilibrated in the electrophoresis buffer for 20 minutes. Electrophoresis was 
conducted for 20 minutes at 25 V using an electrophoresis compact power supply. 
Following electrophoresis, the slides were neutralized by immersing it into 0.4 M 
Tris-HCI (pH 7.5) for 5 minutes at room temperature. The DNA was then detected by 
adding a drop (20 f.!l) of ethidium bromide (20 f.!g/ml) on to the slide, 1etting the 
solution cover the slide. The slides were observed under a fluorescence microscope 
equipped with an excitation filter of 510-560 nm and a barrier filter of 590 nm. 
Quantitative analysis of DNA damages was achieved by counting the number of 
oocytes with damaged DNA (showing the cornet tail) and also by counting the 
different degrees of damages as judged by recording the 1ength of the DNA tail. The 
length of DNA tail was measured by calculating the distance between the edge of 
cornet head and the end of the tail using Microsoft photo editor software (Figure 3). 
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Figure 3. Mouse oocytes subjected to cornet assay. Note that a) the bulk of DNA of 
oocyte was no fragmentation; b) the fragmented DNA of the oocyte has migrated out 
from the membrane. The direction of electrophoresis is from left to right and the 
cornet tail containing the DNA fragments that was stained by ethidium bromide. Scale 
bar indicates 20 ~m. 
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In-vitro fertilization (IVF) and embryo developmental culture 
COCs were removed from cumulus cens before IVF by the previously mentioned 
method. The mature oocytes were washed twice in NF-medium (mHTF containing 
3.0 mg/ml BSA), and then 10-15 COCs were placed into 50 f..LI of micro drop 
IVF-medium, RTF (Quinn et al., 1995), under mineraI oil that were prepared at least 2 
hours in advance and equilibrated at 37°C in 5% C02 incubator. Epididymal sperm 
suspensions are prepared from the male mice, and pre-incubated for 60 minutes in 
mRTF medium containing 9.0 mg/ml BSA to ensure sperm capacitation. The final 
concentration of 2 xl 06 spermlml was introduced into 50 f..LI of micro-drop contained 
., 
the maximum of 15 oocytes. Sperm and oocytes were incubated together for 4-6 hours, 
and then the oocytes were washed to place into 20 f..LI of modified KSOM (mKSOM; 
Lawitts and Biggers, 1993) microdrop under mineraI oil for further developmental 
culture at 37°C a high humidified and 5% CO2 incubator. Embryo developmental 
medium (mKSOM) contained 1.0 mg/ml BSA. The cleavage rate was confirmed 24 
hours post-insemination, and then the cleaved embryos continue culture until day 5 
(120 hours post-insemination) without changing the medium. At the end of culture, the 
percentages of blastocyst formation and the hatched blastocysts were assessed, and 
then provided for differential staining. 
Differentiai staining of blastocysts 
At the end of culture (120 hours), the blastocysts were fixed and stained with the 
method of differential staining to distinguish inner cell mass (leM) and trophectoderm 
(TE) cens. The differential staining of ICM and TE cens was performed according to 
Thouas (2001) with minor modifications. Briefly, zona-intact blastocysts were first 
incubated in Solution 1 (500.0 f..LI) including 1% Triton-lOO and 100 f..Lg/ml propidium 
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iodide (PI; Sigma) in BSA-free mHTF-HEPES for 10 seconds or until trophectoderm 
visibly changed its color to red and shrank slightly. Blastocysts were then immediately 
transferred to Solution 2 (500.0 f!l) containing 25 f!g/ml bisbenzimide (Hoechst 33342; 
Sigma) in 100.0% ethanol and stored at 4°C for ovemight in the dark. Blastocysts 
were mounted onto a slide in a drop of glycerol, taking care to avoid carrying 
excessive amounts of Solution 2, gently flattened with a coverslip and visualized for 
cell counting. The nuclei of blastocyst were observed immediately under fluorescence 
microscope equipped with a UV filter (with excitation set at 355-530 nm and emission 
at 465-615 nm with a long pass filter). The nuclei of the ICM were labeled with 
Hoechst 33342 appeared blue and the nuclei of the TE cells were stained with both PI 
and Hoechst 33342 fluoresced pink (Figure 4). 
Experimental design 
The experiments in the present study were performed to compare (1) the quality of 
in-vivo and in-vitro matured oocytes and subsequent embryonic development 
following IVF, and (2) the effect of gonadotropin stimulation on oocyte quality and 
subsequent embryonic development following IVF. Therefore, the source of in-vivo 
matured oocytes can be divided into two groups: a) natural, post-ovulation; b) 
stimulated, post-ovulation (PMSG + hCG). The source of in-vitro matured oocytes 
also can be divided into two groups: c) natural, pre-ovulation; d) stimulated, 
pre-ovulation (PMSG alone). The experiments were performed separately to compare 
in vivo matured oocytes versus in vitro matured oocytes, naturally ovulated oocytes 
versus superovulated oocytes, and immature oocytes derived from PMSG priming 
versus non-priming, respectively. 
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Statistic analysis 
For evaluation of the differences between groups, the data on the percentage of oocyte 
maturation, fertilization and embryonic development were checked for homogeneity, 
and pooled and compared by analysis of variance using the Newman-Keuls' test (Steel 
and Torrie, 1980). The results of the migration of DNA fragmentation and the 
numbers of leM and TE cells of blastocyst were presented as mean ± SD and carried 
out by unpaired, two-tailed student t-test. Differences were considered statistically 
significant at P< 0.05 levels. 
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Figure 4. DifferentiaI staining of mouse blastocyst. The nuclei of leM were 
labeled by Hoechst 33342 alone showing with blue fluorescence and the nuclei of 
TE cells were stained with both PI and Hoechst 33342 fluoresced with pink. Scale 
bar indicates 20 !lm. 
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RESULTS 
In-vivo matured oocytes versus in-vitro matured oocytes 
As shown in Table 1, the percentages of cleavage and blastocyst formation are 
significantly different (P<O.05) between in vivo and in vitro matured oocytes derived 
from naturally cycling mice. Similarly, the percentages of cleavage and blastocyst 
formation are significantly higher (P<O.05) in in vivo matured oocytes compared to in 
vitro matured oocytes when they were derived from gonadotropin-stimulated mice 
(Table 2). 
Naturally ovulated oocytes vs. superovulated oocytes 
As Figure 5 shown, there are no different in the percentages of cleavage and 
blastocyst formation between naturally ovulated oocytes and superovulated oocytes. 
Immature oocytes derived from naturally cycling ovaries vs. PMSG primed 
ovaries 
There are no differences in oocyte maturation rates between immature oocytes derived 
from naturally cycling mice and PMSG primed mice (Figure 6). As shown in Figure 
7, although there are no differences in cleavage rates between immature oocytes 
derived from naturally cycling mice and PMSG primed mice, the percentages of 
blastocyst formation are significantly higher (P<O.05) in immature oocytes derived 
PMSG primed mice compared to the immature oocytes derived from naturally cycling 
mice. 
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Table 1. The percentages of cleavage and blastocyst fonnation of in vivo and in 
vitro matured oocytes derived from naturally cycling mice (9 replicates) 
No. of % (mean± SD) 
Group oocytes 
examined Cleavage Blastocysts * 
Natural, post-ovulation 
(In vivo) 113 85.5 ± 14.8 a 80.1 ± 12.3 a 
N atural, pre-ovulation 
(In vitro) 320 61.5 ± 13.3 b 18.7±Il.1 b 
* Based on the number of cleaved embryos. 
a,b Different superscripts within column denote a significant difference (P< 0.05). 
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Table 2. The percentages of cleavage and blastocyst fonnation of in vivo and in 
vitro matured oocytes derived from gonadotropin stimulated mice (7 
replicates) 
No. of % (mean± SD) 
Group oocytes 
examined Cleavage Blastocyst * 
Stimulated, post-ovulation 
(In vivo) 554 86.1 ± 6.5 a 81.1 ± 14.2 a 
Stimulated, pre-ovulation 
(In vitro) 392 66.9 ± 11.1 b 34.0 ± 15.9 b 
* Based on the number of cleaved embryos. 
a,b Different superscripts within column denote a significant difference (P< 0.05). 
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Figure 5. The effect of gonadotropin stimulation on mouse oocyte quality and 
subsequent embryonic development in vitro (6 replicates). There are no differences in 
the rates of c1eavage and blastocyst formation between in vivo matured oocyte with 
and without gonadotropin stimulation. Total of 587 oocytes were examined. 
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Figure 6. In vitro maturation of immature mouse oocytes primed with or without 5 lU 
PMSG before collection (7 replicates). There is no difference between these two 
groups. Total of 662 in vitro matured oocytes were examined. 
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Figure 7. The effect of PMSG priming prior to immature mouse oocyte collection on 
oocyte quality and subsequent embryonic development in vitro (6 replicates). 
Although there are no differences in cleavage rates between two groups, the blastocyst 
formation rates are significantly different (P<O.05) between these two groups. Total of 
571 in vitro matured oocytes were examined. 
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DNA fragmentation 
As shown in Table 3, the percentages of oocytes with cornet tails are significantly 
higher in in-vitro matured oocytes compared to in vivo matured oocytes. However, 
there are no differences in the percentage of oocytes with cornet tails between 
naturally ovulated oocytes and superovulated oocytes and between immature oocytes 
derived from naturally cyc1ing mice and derived from PMSG primed mice. The length 
of cornet tails is also significantly longer in the oocytes matured in vitro than in the 
oocytes matured in vivo. However, there are no differences in the length of cornet tails 
between in naturally ovulated oocytes and superovulated oocytes and between 
immature oocytes derived from naturally cyc1ing mice and derived from PMSG 
primed mice. 
~. Cell numbers of TE and ICM 
1 
As shown in Table 4, total cell numbers of blastocyst are significantly different 
(P<O.05) between in-vivo and in-vitro matured oocytes. However, there are no 
• differences in total cell numbers of blastocyst between naturally ovulated oocytes and 
superovulated oocytes and between immature oocytes derived from naturally cyc1ing 
mice and derived from PMSG primed mice. Although there are significantly different 
(P<O.05) in the numbers of TE cells and lCM respectively between in-vivo and in 
-vitro matured oocytes, there are no differences in the numbers of TE cells and lCM 
respectively between immature oocytes derived from naturally cyc1ing mice and 
derived from PMSG primed mice. There are also no differences in ratio of TE 1 leM 
among groups. 
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Table 3. Comparison of DNA fragmentation of in vivo and in vitro matured 
oocytes derived from naturally cycling or gonadotropin stimulated mice 
Group 
Natural, post-ovulation 
(In vivo) 
Natural, pre-ovulation 
(In vitro) 
Stimulated, post-ovulation 
(In vivo) 
Stimulated, pre-ovulation 
(In vitro) 
No. of 
oocytes 
examined 
30 
38 
30 
32 
No. of 
oocytes with 
cornet tail (%) 
20 (66.7)' 
38 (100.0) b 
24 ( 80.0)' 
30 (93.8) b 
The length 
of cornet 
tail (f.!m) 
14.2 ± 7.0' 
27.4 ± 12.3 b 
12.9 ± 4.8 • 
23.0±11.2 b 
a,b Different superscripts within column denote significant differences (P< 0.05). 
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Table 4. Comparison of mean cell number and trophectoderm (TE) and inner cell mass (lCM) in blastocysts produced from in vivo and in vitro 
matured oocytes derived from naturally cycling or gonadotropin stimulation controlled mice 
Group 
Natural, post-ovulation 
(In vivo) 
Natural, pre-ovulation 
(In vitro) 
Stimulated, post-ovulation 
(In vivo) 
Stimulated, pre-ovulation 
(In vitro) 
No. of 
blastocysts 
examined 
20 
16 
20 
20 
Total 
64.7 ± 13.1 a 
46.6 ± 8.1 b 
62.9 ± 7.3 a 
42.9 ± 9.1 b 
a,b Different superscripts within column denote significant differences (P< 0.05). 
Cell number (mean ± SD) 
TE ICM TE/ICM 
45.3 ± 10.2 a 19.3 ± 3.3 a 2.3 ± 0.4 a 
33.6 ± 6.1 b 13.0 ± 3.2 b 2.6 ± 0.5 a 
45.4 ± 6.4 a 17.5±3.7 a 2.5±0.7 a 
30.3 ± 6.6 b 12.6 ± 4.1 b 2.4 ± 0.6 a 
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DISCUSSION 
The results from the present study demonstrate that mouse oocytes matured in-vivo 
are more competent than those matured in-vitro in term of oocyte quality, that the 
capacity of embryonic development in- vivo matured mouse oocytes are not improved 
by ovarian stimulation using PMSG, and that PMSG priming prior to immature mouse 
oocyte retrieval is beneficial to subsequent embryonic development in-vitro. 
Although earlier paper indicated that relatively higher percentage of blastocyst 
development was observed from in-vitro matured mouse oocytes (Schroeder and 
Eppig, 1984), it is still a common believe in mammals that in-vitro matured oocytes 
have less developmental capacity than in-vivo matured oocytes, evidenced by the 
proportion of oocytes developing to the blastocyst stage and blastocyst quality (Sutton 
et al., 2003). This low developmental capacity of in-vitro matured oocytes was 
proposed due to a deficient cytoplasmic maturation (Thibault, 1977), but the real 
reason that is still large1y unknown. Recently, it has been indicated that in-vitro 
matured oocytes possess the different positioning of mitochondria and ATP content in 
the cytoplasm (Combelles and Albertini, 2003) as well as improper coupling 
cytoskeletal remodeling (Sanfins et al., 2004). Indeed, there are many differences in 
morphologie and molecular aspects between in-vitro and in-vivo matured oocytes 
(Hyttel et al., 1997; Lonergan et al., 2003; Nimura et al., 2004). The results from the 
present study indicate that although DNA fragmentation was not different among 
immature oocytes just collected from the ovaries regardless of gonadotropin priming 
or not (data not shown), the proportion of DNA fragmentation and the length of cornet 
tails were significantly increased in in-vitro matured oocytes compared to those 
in-vivo matured oocytes. This suggests that one of the major reasons for lower 
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developmental competence in in-vitro matured oocytes 1S due to genom1c 
fragmentation during oocyte maturation culture in-vitro. 
Oocyte maturation involves a complex process of molecular and structural 
changes between resumption of the frrst meiotic cell cycle and cell cycle arrest at 
metaphase of meiosis II. Many factors may influence quality of in-vitro matured 
oocytes, such as medium composition and culture atmosphere. It has been indicated 
that one of the major differences between in-vitro and in-vivo environment is that 
in-vitro culture condition accumulates reactive oxygen species (ROS) inducing 
apoptotic cell death (Hockenbery et al., 1993; Murdoch, 1998). Several antioxidant 
enzymes may protect the oocyte against peroxidative damage, such as catalase, 
Cu-Zn-superoxide dismutase, Mn-superoxide dismutase, glutathione peroxidase, and 
y-glutamyl-cysteine synthetase (Li et al., 1993). It has been shown that these enzyme 
transcripts are stored during oocyte maturation from the germinal vesicle stage to 
metaphase II stage, suggesting that these enzymes can be considered as markers of 
cytoplasmic maturation of the oocytes (El Mouatassim et al., 1999). This may explain 
why there is higher proportion and longer length of DNA fragmentation and cornet 
tails in in-vitro matured oocytes compared to in vivo matured oocytes. However, the 
mechanism of DNA fragmentation in the oocytes during culture in-vitro needs to be 
further confirmed and investigated. 
There is limited information on maturation of immature mouse oocytes. 
Most information available is from bovine model. It appears that the quality of 
blastocysts yielded from in-vitro matured bovine oocytes is po or if compared to that 
produced from in-vivo matured oocytes as manifested by morphology (Fair et al., 
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2001), metabolism (Khurana and Niemann, 2000), and gene expression (Niemann and 
Wrenzycki, 2000; Knijn et al., 2002; Rizos et al., 2002). These differences affect the 
survival rates of bovine blastocysts following cryopreservation (Enright et al., 2000; 
Rizos et al., 2001). Indeed, pregnancy rates following the transfer of in-vivo 
matured oocytes have superior and greater implantation rates than those of in-vitro 
matured oocytes in animaIs and human (Holm et al., 1996; Hasler, 2000; Chian et al, 
2004). In addition, there are many evidences in literature to suggest that although 
morphologically normal blastocysts were produced from in-vitro matured oocytes, 
those blastocysts were far different in ultrastructure, metabolism and gene. expression 
when compared to blastocysts from in-vivo matured oocytes (Hyttel and Niemann, 
1990; Iwasaki et al., 1990; Boni .et al., 1999; Khurana and Niemann, 2000; Kniji et 
al., 2002). The results from the present study indicate that total cell number of 
blastocyst was less in in-vitro matured oocytes than those in vivo matured oocytes 
(Table 4). However, there were no differences in ratio of TE cells and ICM between 
in-vitro and in-vivo matured oocytes. This indicates that most likely poor quality 
blastocyst produced by in-vitro matured oocytes is related to the total cell number of 
blastocyst other than the ratio of TE cells and ICM. 
Ovarian stimulation by gonadotropin injections yields higher numbers of 
oocytes for embryo production and transfer. Animal model studies have revealed 
detrimental effects of gonadotropin stimulation on oocyte quality and its embryos 
(Moor et al., 1985; Sakai and Endo, 1987; Ertzeid and Storeng, 1992; 2001; Blondin 
et al., 1996; McKieman and Bavister, 1998; Van der Auwera and D'Hooghe, 2001). 
ln mouse model, the ovarian stimulation regimen involves a single injection PMSG 
with predominantly FSH-like activity to induce the development of multiple foUicles 
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and followed by hCG administration with LH activity to trigger oocyte maturation and 
ovulation. It is possible that gonadotropin stimulation results in modification of steroid 
profiles, altering the microenvironment of the developing follicles and their enclosed 
oocytes (Szoltys et al., 1994). It appears that ovarian stimulation with gonadotropins 
enhances oocyte availability but compromises oocyte developmental competence. In 
fact, infertile women undergoing successive stimulation cycle with gonadotropins 
show decreased rates of pregnancy (Meldrum et al., 1998). It is important to mention 
here that although the principle is similar, ovarian stimulation regimens used in human 
infertility treatment for IVF are quite different from the CUITent mouse superovulation 
protocol. Human ovarian stimulation regimens involve longer (up to 3 weeks) and 
multiple doses ofFSH injection. Recently it has been reported that ovarian stimulation 
influences oocyte developmental competence and aneuploidy formation (Hodges et 
al., 2002; Combelles and Albertini, 2003). Furthermore, more recently it has been 
reported that exposure to high levels of FSH during IVM can accelerate nuclear 
maturation but induce chromosomal abnormalities (Roberts et al., 2005). The nature 
of the defects caused by exogenous ovarian stimulation on oocyte quality is still 
unc1ear. However, the results from the present study suggest that there is no difference 
in their embryonic development potential in-vitro between, stimulated-post-ovulated 
oocytes and natural-post-ovulated oocytes (Figure 3). Nevertheless, it is important to 
investigate further the cytogenetic aspects of the oocytes derived from ovarian 
stimulation with gonadotropins. 
The endocrine environment of the follic1e in the latter stage of 
folliculogenesis c1early has a profound impact on oocyte quality. Many attempts 
have made to improve oocyte maturation before immature oocyte retrieval (Hardy et 
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al., 2000), suggesting that the quality of the foIlicular environment from which the 
immature oocytes originate is a major determining factor (Sutton et al., 2003). 
Interestingly, study in rhesus monkeys has indicated that mild ovarian stimulation 
with FSH in the early follicular phase prior to retrieval immature oocytes markedly 
improved the proportion of oocyte meiotic competence and fertilization as weIl as 
embryonic development (Schramm and Bavister, 1994). Wynn et al. (1998) also 
examined the potential benefits of FSH priming on human oocyte quality before 
immature oocyte retrieval, suggesting that more oocyte can be retrieved and matured 
in-vitro. However, it has been indicated that priming with FSH for 1 or 3 days in 
human early follicular phase resulted in no difference in the recovery rate of immature 
oocytes, maturation and fertilization as well as embryonic development in-vitro 
(Trounson et al., 1998; 2001). The results from the present study demonstrate that 
priming with FSH prior to immature oocyte retrieval improves the potential of the 
embryonic deve10pment in-vitro (Figure 5). The further research is required to 
confirm the mechanism of this beneficial effect of priming with FSH before immature 
oocyte retrieval. It is possible that the provision of additional FSH promote the 
proliferation of follicular granulosa or cumulus cells, steroid production through 
intercellular signaling and additional mRNA synthesis in the oocyte cytoplasm. 
41 
CONCLUSIONS 
The results of the present study demonstrate that mouse oocytes matured in-vivo are 
more competent than those matured in-vitro in term of oocyte quality, suggesting that 
this may be due to less DNA damage from in-vivo matured oocytes. The potential of 
embryonic development of in-vivo matured oocytes is not promoted by ovarian 
stimulation using PMSG. PMSG priming prior to immature oocyte retrieval is 
beneficial to subsequent embryonic deve10pment in-vitro. 
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APPENDICES 
AppendixA: Animais (CD-l strain mice) 
Figure 8. The mice were housed in a temperature- and light-controlled room, and free 
access to the food and water under a photoperiod of 12 hours-light and 12 hours-dark. 
The experimental protocols and animal handling procedures were reviewed and 
approved by Animal Ethics Committee of McGill University. 
59 
Appendix B: Media compositions 
Table 5. Human TubaI Fluid (HTF)* 
Component 
CaCL2·2H20 
MgS04 • 2H20 
NaCL 
KCL 
KH2P04 
NaHC03 
Na-pyruvate 
Na-lactate 
Glucose 
Penicillin 
Streptomycin 
Phenol red (1 %) 
mM 
2.04 
0.20 
101.60 
4.70 
0.37 
25.00 
0.33 
21.40 
2.80 
g/L 
0.301 
0.050 
5.931 
0.350 
0.050 
2.100 
0.036 
3.998 
0.50 
0.006 
0.050 
0.005 
* Quinn P, Kerin JF and Warnes GM 1985 Improved pregnancy rate in human in vitro 
fertilization with the use of a medium based on the composition ofhuman tubaI fluid. 
Fertility and Sterility 44,493-498. 
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Table 6. Washing medium (mHTF-HEPES)* 
Component mM g/L 
CaCL2·2H20 2.04 0.3000 
MgS04 ·2H2O 0.20 0.0492 
NaCL 101.60 5.9375 
KCL 4.70 0.3496 
KH2P04 0.37 0.0504 
NaHC03 25.00 2.1000 
HEPES 20.14 4.8000 
Glucose 2.80 0.5000 
N a-pyruvate 0.33 0.0365 
L-glutamine 2.00 0.2920 
Na-lactate 21.40 3.998 
Penicillin 0.006 
Streptomycin 0.050 
Phenol red (1%) 0.005 
* Containing Img BSAIml 
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Table 7. IVM-medium 
Inorganic Salt: mg/L 
NaCI 6800.0000 
KCI 400.0000 
NaHC03 1250.0000 
NaH2P04'H2O 125.0000 
CaCh 200.0000 
MgS04 98.0000 
Amino Acids: mg/L 
L-Alanine 8.9000 
L-Arginine 126.4000 
L-Asparagine 13.2000 
L-Aspartic Acid 13.3000 
L-Cystine 24.0000 
L-Glutamic Acid 14.7000 
L-Glutamine 292.0000 
Glycine 7.5000 
L-Histidine'HCI'H2O 42.0000 
L-Isoleucine 52.4000 
L-Leucine 52.4000 
L-Lysine'HCI 72.5000 
L-Methionine 15.1000 
L-Phenylalanine 33.0000 
L-Proline 11.5000 
(-- L-Serine 10.5000 
L-Threonine 47.6000 
L-Tryptophan 10.2000 
L-Tyrosine 36.0000 
L-Valine 46.8000 
Vitamins: mg/L 
D-Ca Pantothenate 1.0000 
Choline Chloride 1.0000 
Folic Acid 1.0000 
i-Inositol 2.0000 
Nicotinamide 1.0000 
Pyridoxal·HCI 1.0000 
Riboflavin 0.1000 
Thiamine'HCI 1.0000 
Other Components: mg/L 
D-Glucose 1000.0000 
Sodium Pyruvate 110.0000 
Cysteamine 7.7140 
Phenol Red 5.0000 
Penicillin G 50.0000 units 
Streptomycin 50.0000 J.1g 
FSH 75.0000 IU* 
LH 75.0000 IU* 
f' 
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Table 8. Fertilization and spenn capacitation media (mHTF)* 
Component 
CaCL2·2H20 
MgS04 ·2H20 
NaCL 
KCL 
KH2P04 
NaHC03 
Glucose 
Na-pyruvate 
L-glutamine 
Na-lactate 
Penicillin 
Streptomycin 
Phenol red (1%) 
mM 
2.04 
0.20 
101.60 
4.70 
0.37 
25.00 
2.80 
0.33 
2.00 
21.40 
g/L 
0.301 
0.050 
5.931 
0.350 
0.050 
2.100 
0.50 
0.0365 
0.292 
3.998 
0.006 
0.050 
0.005 
* Fertilization medium: 4mg BSA/ml; Spenn capacitation medium: 9mg BSAIml 
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Table 9. Embryo development medium (medium KSOM)* 
Component 
CaCL2 .2H20 
MgS04 ·2H20 
NaCL 
KCL 
KH2P04 
NaHC03 
Glucose 
N a-pyruvate 
L- glutamine 
Na-lactate 
Penicillin 
Streptomycin 
mM 
1. 71 
0.20 
95.00 
2.50 
0.35 
25.00 
0.20 
0.20 
1.00 
10.00 
EDTA (disodium salt) 0.01 
MEM essential amino acids (X50) 
MEM non-essential amino acids (X100) -
Phenol red (1 %) 
* Containing BSA 1.0 mg/ml 
g/L 
0.2510 
0.0492 
5.5950 
0.1800 
0.0475 
2.1000 
0.0365 
0.0220 
0.1450 
1.1200 
0.0060 
0.0500 
0.0038 
10.0ml 
5 .0 m 1 
0.0050 
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Appendix C: IVM Medium preparation 
The immature COCs (maximum of 10) are incubated in an Organ Tissue Culture Dish 
(Falcon, 60 X 15 mm) containing 1 ml Oocyte Maturation Medium supplemented 
with a final concentration of 75 mIU/ml FSH and 75 mill/ml LH at 37°C in an 
incubator with an atmosphere of 5% CO2 and 95% air with high humidity (or with 
triple gas mixture (90% N2, 5% C02, and 5% 02) and 100% humidity). Oocyte 
Maturation Medium should be prepared for equilibration at least two hours before 
immature oocyte retrieval (practically, it can be made one day before). A brief 
description of the procedures involved in the preparation of Oocyte Maturation 
Medium follows: 
a) Place 10.0 ml of Oocyte Maturation Medium into a test tube; 
b) Dissolve completely 1 ampoule of75 lU FSH and 75 lU LH into (a); 
c) Place 9.90 ml offresh Oocyte Maturation Medium into a test tube; 
d) Take 100.0 III FSH and LH dissolved as per item (a) and transfer into (c); 
e) Prepare 3 Organ Tissue Culture Dishes for each patient. In each dish, the 
inner well contains 1 ml of (c) and the outer well 2 ml of (c); 
f) Cover the Organ Culture Dish with the dish cover and place it in the 
incubator. 
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Figure 9. Organ Tissue Culture Dish (60 X 15 mm; Falcon) contained 1.0 ml 
IVM-medium in the inner-well and 2.0 ml out-weIl. 
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Appendix D: Preparation of Washing, Fertilization, Sperm capacitation and 
Embryo development media 
Make above (1) Washing medium, (2) Fertilization medium, (3) Sperrn 
capacitation medium and (4) Embryo development medium in advance and keep it 
at 4°C or aliquot 10 ml frozen keep at -80°C; 
• Add required amount of BSA in the medium and then warrn up to dissolve (30 -
60 min) 
• Immediately prepare dishes using these media 
• 10 ml Washing medium (1 mg BSAlml) 
10 ml Fertilization medium (4 mg BSA/ml) 
10 ml Sperrn capacitation medium (9 mg BSA/ml) 
10 ml Development medium (1 mg BSAlml) 
• Filter with 0.22 )lm filter 
• Immediately prepare dishes using these media 
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Figure 10. The media were filtered with 0.22 /-lm filter and immediately prepare 
dishes using these media. 
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Appendix E: Preparation of culture dishes 
The dishes can be prepared before killing the mice, and also can be prepared the day 
before an IVE If killing one male and two female mice, you could prepare 1 sperm 
capacitation dish, 2 fertilization dishes, 2 development dishes, and 2 washing dishes. 
Therefore, the dish number is related how many mice you need for your experiments. 
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60 x 15 mm 
Tissue culture dish 
5.0 ml Mineral oil 
400 ~l 
Sperm capacitation medium 
Figure 11. Sperm capacitation dish 
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1 
35 x 10 mm 
Culture dish 
2.5 ml Mineral oil 
50 III 
F ertilization medium 
Figure 12. Fertilization dish. 
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1 
35xlOmm 
Culture 
dish 
2.5 ml Mineral oil 
50 ~l 
Development medium 
Figure 13. Embryo development dish. 
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Il ml Mineral oïl 
~--------------~-I 
1 
35 x 10 
Culture 
dish 
2.0 ml 
Washing medium 
Figure 14. Washing dish. 
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Appendix F: Insemination 
10 f.ll 
Swim out spenn 
Figure 15. The count of sperm concentration seems not important, and somewhat can 
be between 1-25 x 106 spennJml. Using pipette tip add 10 /-lI sperm collected from the 
edge of spenn capacitation drop let. 
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Appendix G: Cumulus-oocyte complex and Embryo development 
Figure 16. Mouse cumulus-oocyte complexes. 
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Figure 17. 2-cell stage mouse embryos. 
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Figure 18. Blastocyst stage mouse embryos. 
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Figure 19. Hatched mouse blastocysts 
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